Matrix Private Capital Group’s Zimmer Biomet ZBH Stock Holding History

Matrix Private Capital Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,452	Closed	-$207K	–	272
2021 Q3	$207K	Buy	1,452 +7	+0.5%	+$1.03K	0.11%	166
2021 Q2	$226K	Hold	1,445	–	–	0.12%	158
2021 Q1	$225K	Hold	1,445	–	–	0.14%	156
2020 Q4	$217K	Buy	+1,445	New	+$204K	0.16%	146
2020 Q1	–	Sell	-1,520	Closed	-$221K	–	203
2019 Q4	$221K	Buy	+1,520	New	+$210K	0.23%	125

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Matrix Private Capital Group's ZBH Position: Q4 2021 in Review

Matrix Private Capital Group sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 1,452 shares — an estimated $207K sold.

Matrix Private Capital Group first reported a position in ZBH in Q4 2019 and held it in 5 quarters. The position peaked at $226K in Q2 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

Matrix Private Capital Group reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
Matrix Private Capital Group sold 1,452 Zimmer Biomet shares in Q4 2021, an estimated $207K.
Matrix Private Capital Group first reported a position in Zimmer Biomet in Q4 2019 and held it in 5 quarters.
Matrix Private Capital Group's Zimmer Biomet position peaked at $226K in Q2 2021.
998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Matrix Private Capital Group's 13F filing for Q4 2021, filed 14 Feb 2022.